Vol 9 No 2 (2025): Pulmonology and Allergology | Pulmonology and allergology

Skip to main content Skip to main navigation menu Skip to site footer

Published: 2025-09-18

Topical Issues

REPRESENTATIVES OF THE LSMU MA PULMONOLOGY CLINIC AT THE CONFERENCE OF THE LUNG VASCULAR INSTITUTE

Deimantė Hoppenot

112
- PDF (Lietuvių)
SCIENTIFIC SUMMARY PRESENTED AT THE EUROPEAN CYSTIC FIBROSIS CONFERENCE ON THE FIRST EXPERIENCE OF TREATMENT WITH CFTR MODULATORS IN LITHUANIA

Virginija Kalinauskaitė-Žukauskė

113-114
- PDF (Lietuvių)
UPDATED CONSENSUS ON THE DIAGNOSIS AND TREATMENT OF PNEUMONIA IN ADULTS

Skaidrius Miliauskas

115-116
- PDF (Lietuvių)
FOOD ALLERGIES AND INTOLERANCES – A NEW TEXTBOOK FOR STUDENTS AND DOCTORS OF ALL SPECIALTIES INTERESTED IN FOOD ALLERGIES AND INTOLERANCES

Laura Tamašauskienė

117-118
- PDF (Lietuvių)

Pulmonology and allergology

COVID-19 AND PNEUMONIA CAUSED BY INFLUENZA

Neringa Vagulienė

119-123
- PDF (Lietuvių)
Multi-omics: the future of asthma research

ANDRIUS JANUŠKEVIČIUS, KĘSTUTIS MALAKAUSKAS

124-132
- PDF (Lietuvių)
FOOD ALLERGY AND FOOD INTOLERANCE: SIMILARITIES AND DIFFERENCES

Laura Tamašauskienė

133-138
- PDF (Lietuvių)

Disertations

IMMUNE RESPONSE IN ATOPY: POLYMORPHISM OF VITAMIN D RECEPTOR AND VITAMIN D-BINDING PROTEIN GENES

Daina Pavalkienė

139-148
- PDF (Lietuvių)

Scientific articles and reviews

RETROSPECTIVE ANALYSIS OF THE DIAGNOSIS AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN LITHUANIA

Virginija Kalinauskaitė-Žukauskė, SKAIDRIUS MILIAUSKAS, RASA STASIŪNAITYTĖ, KĘSTUTIS MALAKAUSKAS

149-161
IDENTIFYING SUBJECTS AT RISK FOR OBSTRUCTIVE SLEEP APNEA: A COMPARISON OF SCREENING METHODS

Miglė Jurgelėnaitė, GUODA VAITUKAITIENĖ, TOMAS BALSEVIČIUS

162-168
- PDF (Lietuvių)
EVALUATION OF THE EFFICACY OF PEMBROLIZUMAB TREATMENT IN NON-SMALL CELL LUNG CANCER. A SINGLE-CENTRE EXPERIENCE

Pijus Ruokis, JURGITA MATULIONĖ

169-176
- PDF (Lietuvių)
BLEEDING RISK ASSESSMENT WITH THE PE-SARD, PEBSI, AND RIETE SCORES IN PATIENTS WITH ACUTE PULMONARY EMBOLISM DURING THE EARLY ANTICOAGULATION PERIOD

Agnė Kaunienė, DEIMANTĖ HOPPENOT

177-184
- PDF

Pharmacotherapy

GOOD COPD CONTROL AND THE EUROPEAN GREEN DEAL – WHAT DO THEY HAVE IN COMMON?

Kristina Biekšienė

185-190
- PDF (Lietuvių)
THE ROLE OF FLUTICASONE FUROATE/UMECIDINIUM/VILANTEROL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES IN EFFICACY AND TREATMENT ADHERENCE

Ieva Dimienė

192-194
- PDF (Lietuvių)
IMPACT OF THE BECLOMETASONE/FORMOTEROL/GLYCOPYRRONIUM ON SMALL AIRWAYS DYSFUNCTION IN COPD

Virginija Kalinauskaitė-Žukauskė

196-203
- PDF (Lietuvių)
EFFICACY AND SAFETY OF ALECTINIB IN PATIENTS WITH ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER: DATA FROM THE ALEX CLINICAL TRIAL

Jurgita Matulionė

205-210
- PDF (Lietuvių)
THE ROLE OF DRY POWDER INHALERS IN MODERN ASTHMA AND COPD MANAGEMENT: THE COMBINATION OF BUDESONIDE AND FORMOTEROL FUMARATE

Sabina Gasperovič

212-217
- PDF (Lietuvių)
IDIOPATHIC AND PROGRESSIVE PULMONARY FIBROSIS: A REVIEW OF NEW CLINICAL TRIALS

Kęstutis Malakauskas

218-221
- PDF (Lietuvių)
TREATMENT OF NON-SMALL CELL LUNG CANCER PATIENTS WITH NEGATIVE PROGRAMMED CELL DEATH LIGAND EXPRESSION

Gediminas Vasiliauskas

223-225
- PDF (Lietuvių)